Key result
The role of biological markers in diagnosing postoperative infections after colorectal cancer surgery remains unclear despite a large number of studies.
Why the study?
Does the assessment of biological markers improve the diagnosis of postoperative infections in patients undergoing colorectal cancer surgery?
Does the assessment of biological markers improve the diagnosis of postoperative infections in patients undergoing colorectal cancer surgery?
The clinical utility of inflammatory biomarkers for early detection of postoperative infections in colorectal cancer surgery remains uncertain despite numerous studies.
Postoperative infections after colorectal cancer surgery reduce survival and QoL; leaves open the value of novel diagnostics for early intervention.
Infectious complications in colorectal cancer surgery is one of the major problems in postoperative complications structure. The frequency of the latter is 5-22%, and in 5-20% of cases such complications lead to death. It should be noted that the development of postoperative complications leads to a decrease in the quality of life of patients, general and relapse-free survival of patients operated on for colorectal cancer. One of the promising ways to diagnose postoperative infectious complications after surgery is to assess the level of biological markers of plasma inflammation. It can be used to identify patients with a high probability of infection and be an indication for earlier additional methods of diagnosing complications. Currently, biomarkers that are used for early postoperative infection detection include increase in the leukocytes level in peripheral blood, CRP, PCT, CD64 neutrophils and others. Despite the large number of studies, the question of the role of these biomarkers in postoperative infections diagnosis in the patients who under went colorectal cancer surgery remains unclear.
No takes yet. Share an insight, caveat, or question.
Achkasov et al. (2019) conducted a review in Postoperative infections in colorectal cancer surgery. Biological markers of plasma inflammation (leukocytes, CRP, PCT, CD64 neutrophils) was evaluated. The role of biological markers in diagnosing postoperative infections after colorectal cancer surgery remains unclear despite a large number of studies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: